Towa Pharmaceutical Co Ltd 2025 Sustainability Report
Company: Towa Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2025
Type: Sustainability Report
Pages: 23
The report describes Towa Group's FY2024 sustainability activities across climate, resource use, human capital and governance. It reports FY2024 Scope 1, Scope 2 and Scope 3 emissions of 30,077, 28,353 and 1,066,500 t-CO2, respectively, and a 30% Scope 1 and 2 reduction target by FY2030. Waste generated was 5,770 t, with a 61% recycling rate, while CDP scores were B for climate change and A- for water security. The company also reports certification as a KENKO Investment for Health 2025 "White 500" organization.
Services
From bulk PDFs to structured indicators and machine-readable documents.